These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 28780934)
41. A step-by-step microRNA guide to cancer development and metastasis. Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501 [TBL] [Abstract][Full Text] [Related]
42. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767 [TBL] [Abstract][Full Text] [Related]
43. Regulation of mesenchymal phenotype by MicroRNAs in cancer. Yan J; Gumireddy K; Li A; Huang Q Curr Cancer Drug Targets; 2013 Nov; 13(9):930-4. PubMed ID: 24168190 [TBL] [Abstract][Full Text] [Related]
44. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression. Lo PK; Lee JS; Liang X; Sukumar S Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963 [TBL] [Abstract][Full Text] [Related]
45. The emerging role of RUNX3 in cancer metastasis (Review). Chen F; Liu X; Bai J; Pei D; Zheng J Oncol Rep; 2016 Mar; 35(3):1227-36. PubMed ID: 26708741 [TBL] [Abstract][Full Text] [Related]
46. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
48. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma. Yu M; Han G; Qi B; Wu X Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043 [TBL] [Abstract][Full Text] [Related]
49. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer. Sun Y; Yu X; Bai Q Int J Clin Exp Pathol; 2015; 8(10):12775-83. PubMed ID: 26722467 [TBL] [Abstract][Full Text] [Related]
50. EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms. Nachiyappan A; Gupta N; Taneja R FEBS J; 2022 Mar; 289(5):1329-1351. PubMed ID: 34954891 [TBL] [Abstract][Full Text] [Related]
51. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression. Lee JY; Kong G Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000 [TBL] [Abstract][Full Text] [Related]
52. Tumor-associated macrophages and epithelial-mesenchymal transition in cancer: Nanotechnology comes into view. Vakili-Ghartavol R; Mombeiny R; Salmaninejad A; Sorkhabadi SMR; Faridi-Majidi R; Jaafari MR; Mirzaei H J Cell Physiol; 2018 Dec; 233(12):9223-9236. PubMed ID: 30078227 [TBL] [Abstract][Full Text] [Related]
53. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway. Ping H; Guo L; Xi J; Wang D Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer. Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333 [TBL] [Abstract][Full Text] [Related]
55. ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition. Stacy AJ; Craig MP; Sakaram S; Kadakia M Oncotarget; 2017 Jan; 8(2):2114-2129. PubMed ID: 27924063 [TBL] [Abstract][Full Text] [Related]
56. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes. Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350 [TBL] [Abstract][Full Text] [Related]
57. MicroRNAs and signaling networks involved in epithelial-mesenchymal transition. Musavi Shenas MH; Eghbal-Fard S; Mehrisofiani V; Abd Yazdani N; Rahbar Farzam O; Marofi F; Yousefi M J Cell Physiol; 2019 May; 234(5):5775-5785. PubMed ID: 30417364 [TBL] [Abstract][Full Text] [Related]
58. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
59. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation. Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011 [TBL] [Abstract][Full Text] [Related]
60. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism. Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]